The SCI at Imperial College London works with Ministries of Health and Education in sub-Saharan Africa and Yemen to treat their populations for the parasitic “worm” infections, schistosomiasis and soil-transmitted helminthiasis (STH). These infections affect the poorest and most marginalised communities in the world.
The World Health Organization estimates that 206 million people have schistosomiasis and 1.5 billion have STH.
These infections can result in: anaemia, stunted growth, reduced school attendance, impaired cognitive development, reduced worker productivity, and internal organ damage.
However, studies show that treating schistosomiasis and STH can:
- Increase school attendance by up to 255
- Increase future earnings by 40%
- Reverse damaging effects of infections
The majority of SCI-supported programmes treat school-age children (5-14 years old), but can include at-risk adults.
Treatment is cost-effective. £1 provides treatment for three people.
Since its foundation in 2002, SCI has supported the delivery of over 159 million treatments for these infections.